Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 4,487 | 5,536 | 4,403 | 4,930 | 5,630 |
| Cost of Goods | 710 | 1,237 | 1,130 | 1,108 | 1,236 |
| Gross Profit | 3,778 | 4,298 | 3,273 | 3,822 | 4,394 |
| Operating Expenses | 27,428 | 29,664 | 24,615 | 24,904 | 22,139 |
| Operating Income | -22,941 | -25,128 | -21,211 | -20,974 | -17,509 |
| Other Income | 104 | 112 | 117 | 44 | 26 |
| Pre-tax Income | -22,836 | -25,016 | -21,094 | -20,929 | -17,483 |
| Net Income Continuous | -22,836 | -25,016 | -21,094 | -20,929 | -17,483 |
| Net Income | $-22,836 | $-25,016 | $-21,094 | $-20,929 | $-17,483 |
| EPS Basic Total Ops | -5.50 | -6.50 | -5.50 | -5.50 | -4.50 |
| EPS Basic Continuous Ops | -5.81 | -6.37 | -5.37 | -5.37 | -4.80 |
| EPS Diluted Total Ops | -5.50 | -6.50 | -5.50 | -5.50 | -4.50 |
| EPS Diluted Continuous Ops | -5.81 | -6.37 | -5.37 | -5.37 | -4.80 |
| EBITDA(a) | $-22,893 | $-25,088 | $-21,187 | $-20,954 | $-17,491 |